Professional Bio
Dr. Berk is Professor of Medicine, Cardiology, and Pharmacology and the Senior Vice President for Health Sciences at the University of Rochester. Dr. Berk received his M.D. and Ph.D. degrees from the University of Rochester. He has served on the faculties of Harvard Medical School, Emory University, and the University of Washington. Dr. Berk was previously Chairman of Medicine (1999-2006) and Chief of the Cardiology Unit (1998-2003) at the University of Rochester. In addition he was Director of the Aab Cardiovascular Research Institute. Dr. Berk is a fellow of the American Heart Association and the American College of Cardiology, and a member of the Association of American Physicians. Dr. Berk is past-president of the North American Vascular Biology Organization (NAVBO). He is Consulting Editor for Circulation and Circulation Research and is on the editorial boards of ATVB and the Journal of Clinical Investigation. He serves on the Empire State Stem Cell Board Funding Committee and the National Heart, Lung and Blood Institute (NHLBI), Stem Cell Clinical Trial Network and Gene and Cell-Based Therapies Data and Safety Monitoring Board (DSMB).
His research interests include: molecular biology of renin-angiotensin-aldosterone
system; regulation of endothelial cell function especially by shear stress; the role of oxidative stress in vascular biology and the genetic mechanisms of vascular remodeling. Dr. Berk has published widely – more than 250 articles, chapters, and books.
Listed below is Dr. Berk's affiliation:
Bradford C. Berk, M.D., Ph.D.
Professor of Medicine, Cardiology, and Pharmacology
Senior Vice President for Health Sciences
University of Rochester Medical Center
Rochester, New York
US Postal mail should be sent to:
Bradford C. Berk, M.D., Ph.D.
University of Rochester Medical Center
Office of Vice President for Health Sciences
601 Elmwood Avenue, Box 706
Rochester, New York 14642
FEDEX
Bradford C. Berk, M.D, Ph.D.
University of Rochester Medical Center
Office of Vice President for Health Sciences
601 Elmwood Avenue, Box 706, Rm. 1-4337
Rochester, NY 14642
Patient Care Bio
Dr. Berk's research interests include: molecular biology of renin-angiotensin-aldosterone system; regulation of endothelial cell function especially by shear stress; the role of oxidative stress in vascular biology and the genetic mechanisms of vascular remodeling. Dr. Berk has published widely – more than 250 articles, chapters, and books.
| Vice-chair | Vascular Cell Biology Gordon Conference |
2004 - 2005 |
| Russell Ross Memorial Lectureship in Vascular Biology | Council for Arteriosclerosis, Thrombosis, Vascular Biology |
2003 |
| Theo Tsagaris Memorial Lecture | University of Utah | Salt Lake City, Utah |
2002 |
| Indiana Vascular Society/ICVBM Conference | University of Indiana | Indianapolis, Indiana |
2002 |
| Pfizer Visiting Professor | University of Iowa | Iowa City, Iowa |
2002 |
| Borun Visiting Professor in Cardiology | UCLA Medical Center | Los Angeles, CA |
1999 |
| Annual Pulsifer Lecture, Guest Speaker | Rochester Academy of Medicine |
1999 |
| Pfizer Visiting Professor of Cardiovascular Disease | Wayne State University School of Medicine |
1995 |
| Marion Young Scholar Award | American Society for Hypertension |
1992 |
| Katz Prize Finalist | American Heart Association |
1986 |
| Young Investigator's Award | American College of Cardiology |
1985 |
| Robert Kates Memorial Prize in Research, Doran J. Stephens Prize in Medicine | Alpha Omega Alpha |
1981 |
| Phi Beta Kappa, John Albree Jr. Class of 1981 Memorial Fund Award for History | John Woodruff Simpson Postgraduate Scholarship in Medicine |
1975 |
| Medical Scientist Training Program (Pharmacology) | University of Rochester | Rochester, NY |
1975 - 1981 |
| Woods Hole Oceanographic Institution Fellowship (Microbiology) | Woods Hole Oceanographic Institute | Woods Hole, MA |
1974 |
Thioredoxin Interacting Protein (TXNIP or VDUP1) as a Regulator of Vascular Function
United States Serial NO.: 11/814,442
Filed Date: January 20, 2006
Title: Thioredoxin Interacting Protein (TXNIP) as a Regulator of Vascular Function
Invented by: Bradford Berk
|
Thioredoxin Interacting Protein (TXNIP or VDUP1) as a Regulator of Vascular Function
United States Serial NO.: 2006206376
Filed Date: January 20, 2006
Title: Thioredoxin Interacting Protein (TXNIP as Regulator of Vascular Function
Invented by: Bradford Berk
|
A Novel Anti-Inflammatory Agent for the Treatment of Inflammatory Diseases
United States Serial NO.: 12/678,352
Filed Date: September 16, 2008
Title: Method and Compositions For Treatment or Prevention of Inflammatory Conditions
Invented by: Chen Yan, Jian-Dong Li, Kye-Im Jeon, Xiangbin Xu, Bradford Berk
|
A Novel Anti-Inflammatory Agent for the Treatment of Inflammatory Diseases
United States Serial NO.: 200880117461.X
Filed Date: September 16, 2008
Title: Method and Compositions for Treatment or Prevention of Inflammatory Conditions
Invented by: Chen Yan, Jian-Dong Li, Kye-Im Jeon, Xiangbin Xu, Bradford Berk
|
A Novel Anti-Inflammatory Agent for the Treatment of Inflammatory Diseases
United States Serial NO.: 14/191,219
Filed Date: February 26, 2014
Title: Method and Compositions For Treatment or Prevention of Inflammatory Conditions
Invented by: Chen Yan, Jian-Dong Li, Kye-Im Jeon, Xiangbin Xu, Bradford Berk
|
A Novel Anti-Inflammatory Agent for the Treatment of Inflammatory Diseases
United States Serial NO.: 14/970,028
Filed Date: December 15, 2015
Title: Method and Compositions For Treatment or Prevention of Inflammatory Conditions
Invented by: Chen Yan, Jian-Dong Li, Kye-Im Jeon, Xiangbin Xu, Bradford Berk
|
GIT1 Ankyrin Repeat Domain (GIT1ANK) is a Novel Drug Target of Regulating Angiogenesis
United States Serial NO.: 14/775,936
Filed Date: March 14, 2014
Title: GIT1 Ankyrin Repeat Domain (GIT1ANK) is a Novel Drug Target of Regulating Angiogenesis
Invented by: Bradford Berk, Jinjiang Pang, Syamantak Majumder
|
